Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis

• Published in: Archives of medical sciences. Atherosclerotic diseases 2016, Vol.1 (1), p.e36-49
• Main Authors: Raczkiewicz, Anna, Juszkiewicz, Aleksandra, Kisiel, Bartłomiej, Bachta, Artur, Kur-Zalewska, Joanna, Kłos, Krzysztof, Bujakowska, Olga, Tłustochowicz, Małgorzata, Tłustochowicz, Witold
• Format: Article
• Language: English
• Subjects: Clinical Research
• ISSN: 2451-0629; 2451-0629
• DOI: 10.5114/amsad.2016.60225

The aim of the study was to investigate the presence of subclinical atherosclerosis and predictors of change in carotid intima-media measures in early rheumatoid arthritis patients (eRA) as compared to chronic RA patients and patients without arthritis. Fifty-five consecutive eRA patients were assessed at the time of diagnosis and after 1 year of therapy. Fifty-five sex- and age-matched chronic RA patients and 29 patients without inflammatory disease were used as controls. Carotid artery intima-media thickness (CIMT) and carotid plaques were measured at baseline and after follow-up. In eRA patients ultrasound assessment of hand joints was performed before and after treatment. Carotid artery intima-media thickness was assessed again after 2 years in 44 eRA patients. Carotid artery intima-media thickness progression after 1 year of therapy was higher in eRA patients compared to both control groups ( = 0.017) and correlated with symptoms duration ( = 0.017) and DMARD monotherapy ( = 0.015). Ultrasound progression of hand joint erosions was associated with longer symptoms duration ( = 0.006). After 2 years of observation CIMT progression was similar in all examined groups. We observed rapid CIMT progression during the first year of RA therapy. Longer symptoms duration and less aggressive therapy were associated with CIMT increase.